Blood cancer, also known as hematological malignancy, refers to a group of cancers that affect the blood, bone marrow, and lymphatic system. Recent research in blood cancer has focused on developing new approaches to improve the diagnosis, treatment, and prevention of these diseases. Immunotherapy is a kind of cancer treatment that uses the body's immune system to fight against cancer. Recent research has shown that immunotherapy can be effective in treating blood cancers such as leukemia, lymphoma, and multiple myeloma.
CAR-T cell therapy is a type of immunotherapy that involves genetically modifying a patient's T cells to target cancer cells. Recent research has shown that CAR-T cell therapy can be effective in treating blood cancers such as leukemia and lymphoma. Advances in genomic analysis have enabled researchers to identify genetic mutations and alterations in blood cancer cells that can be targeted by specific treatments. This approach has led to the development of precision medicine approaches for the treatment of blood cancers.
Gene therapy involves the modification of a patient's DNA to treat or cure a disease. Recent research has led to the development of gene therapy approaches for the treatment of blood disorders such as sickle cell anemia and thalassemia. Targeted therapies are drugs that are designed to target specific proteins or genes involved in the development of cancer. Recent research has led to the development of targeted therapies for blood cancers such as chronic myeloid leukemia and lymphoma.
- Hematological Malignancies
- Hematopoietic Stem Cell Transplantation
- Precision Medicine